Home » Early Data With DFF332, Other Key Biomarker Analyses Continue to Inform Approaches in RCC

Early Data With DFF332, Other Key Biomarker Analyses Continue to Inform Approaches in RCC

by Courtney Flaherty | Jul 3, 2024 | Articles | 0 Comments